Healthcare / Medical Care FacilitiesSES
$0.00
-0.00 (-20.00%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 34% · confianza 19%
FCF escenarios
weak_data · normalized FCF $-1.1M · quality 49.7/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
17/100
F
Piotroski
6/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$5M
P/E
N/A
•EV/EBITDA
N/A
•ROE
92.5%
↑Gross Margin
93.1%
↑Debt/Equity
-1.62
↓TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
-50.8%
FCF CAGR
—
FCF margin
-69.3%
FCF / Net income
0.75x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $1.4M · net income $-1.2M · FCF $-942215.0
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $1.4M | $1.4M | $244828.00 | $4.6M | $11.4M |
| Net Income | $-1.2M | $-1.2M | $-1.4M | $-8.4M | $-8.7M |
| EBITDA | $-1.1M | $-1.1M | $-867996.00 | $-1.5M | $-4.5M |
| EPS | -0.00 | -0.00 | -0.00 | -0.01 | -0.02 |
| Gross Margin | 93.1% | 93.1% | 77.5% | 17.9% | 16.3% |
| Operating Margin | -86.0% | -86.0% | -626.5% | -61.1% | -42.6% |
| Net Margin | -91.8% | -91.8% | -588.5% | -182.3% | -76.0% |
| Balance Sheet | |||||
| Debt/Equity | -1.62 | -1.62 | -1.45 | -7.96 | 1.64 |
| Current Ratio | 0.42 | 0.42 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $-942215.00 | $-942215.00 | $-1.1M | $-2.7M | $-2.7M |
| Returns | |||||
| ROE | 92.5% | 92.5% | 91.9% | 1690.7% | -171.0% |
| Valuation | |||||
| P/B | — | — | — | — | 2.21 |
| Growth & Yield | |||||
| Revenue Growth | 455.5% | 455.5% | -94.7% | -59.5% | — |
| EPS Growth | 28.6% | 28.6% | 88.4% | 20.3% | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-20.0%
Start / end P/E
n/dx → n/dx
EPS bridge
-0.00 → -0.00
Residual
-20.0%
EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.